In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FlowCardia: Playing it Safe in Total Occlusions

Executive Summary

Chronic total occlusions remain one of the most significant challenges and opportunities facing interventional cardiologists and radiologists. FlowCardia is looking to succeed where other device companies have failed by emphasizing safety and simplicity.
Advertisement

Related Content

Challenges & Opportunities for CABG Surgery
Industry Perspective - The Medtech Industry: A Look Back at 2006
In Brief January 2007
Total Occlusions: Device Obstacle or Opportunity?
Total Occlusions: Device Obstacle or Opportunity?
LuMend's Breakthrough Break Out
LuMend's Breakthrough Break Out
LuMend Inc.
LuMend Inc.
IntraLuminal Therapeutics Inc.

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002678

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel